Celsion (CLSN) COVID Vaccine Effective in Pre-Clinical Studies Posted byZacks Equity Research September 3, 2021 Leave a comment on Celsion (CLSN) COVID Vaccine Effective in Pre-Clinical Studies Celsion (CLSN) announces data from pre-clinical studies for its investigational vaccine platform as a potential treatment for COVID-19.